Purpose: We evaluated the prognostic criteria for salvage surgery in patien
ts with persistent marker elevation after chemotherapy for metastatic germ
cell tumors.
Materials and Methods: Of 125 men who underwent post-chemotherapeutic resec
tion of residual tumors 30 had persistent marker elevation at surgery. This
group was subdivided into 17 patients with no evidence of disease, 7 dead
of disease and 6 others. Outcome analysis was performed in the subgroups wi
th regard to preoperative and postoperative parameters. Mean followup was 1
20.3 months (range 1 to 228) after surgery.
Results: Of the 30 patients 17 (57%) with persistently elevated tumor marke
rs after chemotherapy were long-term survivors after salvage surgery. Overa
ll persistent viable cancer and teratomatous elements were identified in 64
% and 11% of cases, respectively. Significantly more patients died of disea
se who had a poor prognosis according to International Germ Cell Cancer Col
laborative Group guidelines. Embryonal carcinoma was the predominant initia
l histology in this group and residual disease was more often located at va
rious sites, for example the viscera, with a lower chance of complete surgi
cal resection. Marker status before surgery, and chemotherapeutic pretreatm
ent and postoperative histological findings did not differ significantly in
patients with no evidence of disease and those dead of disease.
Conclusions: Salvage surgery results in long-term success in greater than 5
0% of patients. Complete resection is the most important single parameter f
or a favorable outcome. Even patients with visceral metastasis benefit from
surgery. Our data do not justify omitting surgery in certain subgroups.